Tito R Mendoza (Tito Mendoza)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Topics

Positive Breast Cancer

Psychometric Properties

Top Venues

Scientific reports

Journal of patient-reported outcomes

Cancer medicine

Neuro-oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Charles S Cleeland, Karen N Keating, Brian Cuffel, Cem Elbi, Jonathan M Siegel, Christoph Gerlinger, Tara Symonds, Jeff A Sloan, Amylou C Dueck, Andrew Bottomley, Xin Shelley Wang, Loretta A Williams, Tito R Mendoza
Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma. Scientific reports 14 (1) (2024)
Charles S Cleeland, Karen N Keating, Brian Cuffel, Cem Elbi, Jonathan M Siegel, Christoph Gerlinger, Tara Symonds, Jeff A Sloan, Amylou C Dueck, Andrew Bottomley, Xin Shelley Wang, Loretta A Williams, Tito R Mendoza
Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma. Scientific reports 14 (1) (2024)
Charles S Cleeland, Karen N Keating, Brian Cuffel, Cem Elbi, Jonathan M Siegel, Christoph Gerlinger, Tara Symonds, Jeff A Sloan, Amylou C Dueck, Andrew Bottomley, Xin Shelley Wang, Loretta A Williams, Tito R Mendoza
Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma. Scientific reports 14 (1) (2024)
Sarah Jenkins, Wei Zhang, Seth M Steinberg, Darryl Nousome, Nicole Houston, Xiaolin Wu, Terri S Armstrong, Eric Burton, DeeDee K Smart, Ritu Shah, Cody J Peer, Brett Mozarsky, Oluwatobi Arisa, William Douglas Figg, Tito R Mendoza, Elizabeth Vera, Priscilla Kaliopi Brastianos, Scott L Carter, Mark R Gilbert, Carey K Anders, Caitriona Cahir, Carol Tweed, Karen Lisa Smith, Imran Khan, Stanley Lipkowitz, Patricia S Steeg, Alexandra S Zimmer
Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ajay Sheshadri, Alberto A Goizueta, Vickie R Shannon, David London, Guillermo Garcia Manero, Hagop M Kantarjian, Farhad Ravandi-Kashani, Tapan Mahendra Kadia, Marina Y Konopleva, Courtney D D DiNardo, Sherry Pierce, Abdulrazzak Zarifa, Aya A Albittar, Linda L Zhong, Fechukwu O Akhmedzhanov, Muhammad H Arain, Mansour Alfayez, Ahmad Alotaibi, Mehmet Altan, Aung Naing, Tito R Mendoza, Myrna C B Godoy, Girish Shroff, Sang T Kim, Saadia A Faiz, Dimitrios P Kontoyiannis, Fareed Khawaja, Kristofer Jennings, Naval G Daver
Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort study. Cancer 128 (14) (2022)
David Hui, Nico Nortje, Marina C George, Kaycee Wilson, Diana L Urbauer, Caitlin A Lenz, Susannah Kish Wallace, Clark R Andersen, Tito R Mendoza, Sajid Haque, Sairah Ahmed, Marvin Delgado Guay, Shalini Dalal, Nisha Rathi, Akhila Reddy, Jennifer Leigh McQuade, Christopher R Flowers, Peter Pisters, Thomas A Aloia, Eduardo Bruera
Impact of an Interdisciplinary Goals-of-Care Program Among Medical Inpatients at a Comprehensive Cancer Center During the COVID-19 Pandemic: A Propensity Score Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Tito R Mendoza, David S Hong, Christine B Peterson, Bettzy Stephen, Ecaterina Dumbrava, Shubbam Pant, Apostolia Maria Tsimberidou, Timothy Anthony Yap, Ajay Sheshadri, Mehmet Altan, Goldy George, Lilibeth Castillo, Enedelia Rodriguez, Jing Gong, Vivek Subbiah, Filip Janku, Siqing Fu, Sarina A Piha-Paul, Jordi Rodon Ahnert, Daniel D Karp, Charles Cleeland, Funda Meric-Bernstam, Aung Naing
Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial. Scientific reports 12 (1) (2022)
Sukh Makhnoon, Brooke Levin, Megan Ensinger, Kristin Mattie, Robert J Volk, Zhongming Zhao, Tito R Mendoza, Sanjay S Shete, Laila Samiian, Generosa Grana, Andrew Grainger, Banu Arun, Brian H Shirts, Susan K Peterson
A multicenter study of clinical impact of variant of uncertain significance reclassification in breast, ovarian and colorectal cancer susceptibility genes. Cancer medicine (2022)
Linda Dirven, Maartje E Vos, Tobias Walbert, Terri S Armstrong, David Arons, Martin J van den Bent, Jaishri Blakeley, Paul D Brown, Helen Bulbeck, Susan M Chang, Corneel Coens, Mark R Gilbert, Robin Grant, Rakesh Jalali, Danielle Leach, Heather Leeper, Tito R Mendoza, Lakshmi Nayak, Kathy Oliver, Jaap C Reijneveld, Emilie Le Rhun, Larry Rubinstein, Michael Weller, Patrick Y Wen, Martin J B Taphoorn
Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the Response Assessment in Neuro-Oncology Patient-Reported Outcome (RANO-PRO) initiative. Neuro-oncology practice 8 (4) (2021)
Tito R Mendoza
Especially for neuro-oncologists-minimally important differences for the EORTC QLQ-C30 in glioma patients. Neuro-oncology 23 (8) (2021)
Naomi Q P Tan, Shawn P E Nishi, Lauren M Andring, Tito R Mendoza, Maria Angeles Lopez-Olivo, Laura C Crocker, Karen R Sepucha, Robert J Volk
Impact of the shared decision-making process on lung cancer screening decisions. Cancer medicine 11 (3) (2021)
Tito R Mendoza, Ajay Sheshadri, Mehmet Altan, Kenneth Hess, Goldy George, Bettzy Stephen, Lilibeth Castillo, Enedelia Rodriguez, Jing Gong, Christine Peterson, Jordi Rodon Ahnert, Siqing Fu, Sarina A Piha-Paul, Shubham Pant, Ecaterina Dumbrava, Timonthy A Yap, Filip Janku, Apostolia M Tsimberidou, Vivek Subbiah, Daniel D Karp, Abdulrazzak Zarifa, Lacey M McQuinn, Charles Cleeland, David S Hong, Aung Naing
Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory. Journal for immunotherapy of cancer 8 (2) (2021)
Tito R Mendoza, Loretta A Williams, Qiuling Shi, Xin Shelley Wang, Oluwatosin Bamidele, Jeanie F Woodruff, Charles S Cleeland
The Treatment-induced Neuropathy Assessment Scale (TNAS): a psychometric update following qualitative enrichment. Journal of patient-reported outcomes 4 (1) (2020)
Karin Piil, Meagan S Whisenant, Tito R Mendoza, Terri Armstrong, Charles Cleeland, Sara Nordentoft, Loretta A Williams, Mary Jarden
Psychometric validity and reliability of the Danish version of the MD Anderson Symptom Inventory Brain Tumor Module. Neuro-oncology practice 8 (2) (2020)
Tito R Mendoza, Loretta A Williams, Karen N Keating, Jonathan Siegel, Cem Elbi, Anna K Nowak, Raffit Hassan, Brian Cuffel, Charles S Cleeland
Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM). Journal of patient-reported outcomes 3 (1) (2019)
Tito R Mendoza, Kenneth L Kehl, Oluwatosin Bamidele, Loretta A Williams, Qiuling Shi, Charles S Cleeland, George Simon
Assessment of baseline symptom burden in treatment-naïve patients with lung cancer: an observational study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 27 (9) (2019)
Martin W Schoen, Ethan M Basch, Lori L Hudson, Arlene E Chung, Tito R Mendoza, Sandra A Mitchell, Diane St Germain, Paul Baumgartner, Laura Sit, Lauren J Rogak, Marwan Shouery, Eve R Shalley, Bryce B Reeve, Maria R Fawzy, Nrupen A Bhavsar, Charles S Cleeland, Deborah Schrag, Amylou C Dueck, Amy P Abernethy
Software for Administering the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability Study. JMIR human factors 5 (3) (2018)
Loretta A Williams, Meagan S Whisenant, Tito R Mendoza, Shireen Haq, Karen N Keating, Brian Cuffel, Charles S Cleeland
Modification of existing patient-reported outcome measures: qualitative development of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM). Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 27 (12) (2018)